BBLG Stock Analysis: Bone Biologics Corp prepares for its NB1 Bone Graft Device pilot clinical trial, signaling a potential breakthrough. With a price bounceback in sight, investors are eager for the stock's next move. Stay tuned for breaking news and our price prediction on BBLG stock.